ERDERA Clinical Trials Call
ERDERA has opened the first ERDERA Clinical Trials Call (ECTC) to support multinational, GCP‑compliant Phase I, Phase I/II and Phase II interventional clinical trials in rare diseases. Priority areas: paediatric rare diseases; rapidly progressive rare diseases; and rare diseases with no approved therapeutic options or with substantial residual unmet medical need despite existing treatments.
Stage 0 – EOI (mandatory): 1 July – 10 September 2026.
Stage 1 – Short Proposal: 15 September – 29 October 2026.
ERDERA Networking Support Scheme
A competitive funding instrument for networking events to share knowledge on rare diseases and rare cancers
Through this constantly open call, ERDERA supports the organisation of transnational networking events that promote knowledge sharing, research uptake and collaborations among clinicians, researchers, and patients/patient advocacy organizations (PAOs).
These events will strengthen new or expanding research networks on rare diseases and rare cancers in general and promote the inclusion of typically underrepresented countries (UCs) in European rare diseases and rare cancers networks in particular.
With funding of up to €30 000 per networking event, the scheme has been open since May 2025, offering a flexible framework for building the connections essential to meaningful knowledge sharing in rare disease and rare cancers research.
ERDERA Joint Transnational Call
ERDERA Joint Transnational Calls supports interdisciplinary research to address identified gaps. These calls foster cross-border collaboration and align with the strategic priorities of the rare disease community.
IHI call 13
Call 13
IHI call 13 is a two-stage call with topics on accelerating healthcare innovation through networks, reducing animal use in drug safety studies, and decoding the immuno-science of diseases affected by ageing and the immune system.
Topics
Topic 1: A network to boost the next wave of European innovations in healthcare
Topic 3: Decode the immuno-science of age-related immune-mediated diseases
Key deadlines
Short proposal submission deadline: 08 October 2026 at 17:00 Brussels time
Full proposal submission deadline: 21 April 2027 at 17:00 Brussels time
Calls of the European Commission
Please find here the links to calls of the European Commission you can apply to:
HORIZON EUROPE Work Programme
Funding opportunities under Horizon Europe are set out in multiannual work programmes. The Work programme addressing Health is the work programme – cluster 1. The aim of cluster 1 include improving and protecting the health and well-being of citizens of all ages by generating new knowledge, developing innovative solutions and integrating where relevant a gender perspective to prevent, diagnose, monitor, treat and cure diseases.